Back to products
PeptidePower GLP-2T — research vial
GLP-2T Price range: $130.80 through $339.60

AOD-9604

$77.99

Lyophilized powder - research reference material

This material is supplied solely as a laboratory research article. Buyer is responsible for ensuring lawful purchase, handling, storage, and use. We do not provide administration or therapeutic guidance.

AOD-9604 - Modified hGH(176-191) Fragment Analog Peptide, Research Reference Material

FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.

2D chemical structure of AOD-9604 - Modified hGH(176-191) Fragment Analog Peptide, Research Reference Material
Two-dimensional chemical structure. Depiction for identification only.
Amino-acid sequence of AOD-9604 - Modified hGH(176-191) Fragment Analog Peptide, Research Reference Material
Primary amino-acid sequence, N to C. Tiles colored by side-chain class.

Analytical Identity

Identity & nomenclature
Common nameAOD-9604
Amino-acid sequenceYLRIVQCRSVEGSCGF (with disulfide bond between Cys-7 and Cys-14)
Sequence (3-letter)Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
Residues16
CAS Number221231-10-3
PubChem CID71300630
InChIKeyGVIYUKXRXPXMQM-BPXGDYAESA-N
SMILESCCC(C)C(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC1CSSCC(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCCNC(=N)N)CO)C(C)C)CCC(=O)O)CO)C(=O)NCC(=O)NC(CC2=CC=CC=C2)C(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CC3=CC=C(C=C3)O)N
Physicochemical
Molecular formulaC78H123N23O23S2
Molecular weight1815.1 g/mol
Monoisotopic mass1813.8604 Da
AppearanceWhite to off-white lyophilized powder
Physical formLyophilized powder
Quality & provenance
PurityNot less than 98% by HPLC (see lot-specific Certificate of Analysis)
SourceSynthetic
Catalog / SKUAOD-9604

AOD-9604 is supplied as a laboratory research reference material intended for in-vitro and laboratory research use only. Structurally, it is a synthetic 16-residue modified analog derived from the C-terminal region of human growth hormone (residues 176-191), presenting the primary sequence YLRIVQCRSVEGSCGF (Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe) with an intramolecular disulfide bridge locking Cys-7 to Cys-14 into a constrained loop. An N-terminal tyrosine addition distinguishes AOD-9604 from the unmodified parent fragment and provides a UV-active handle useful for 280 nm detection during chromatographic characterization.

The peptide is defined by the molecular formula C78H123N23O23S2, an average molecular weight of 1815.1 g/mol, and a monoisotopic mass of 1813.8604 Da, corresponding to CAS 221231-10-3 and PubChem CID 71300630. Additional cheminformatics identifiers include the InChIKey GVIYUKXRXPXMQM-BPXGDYAESA-N and a canonical SMILES string capturing the disulfide-cyclized backbone, supporting unambiguous cross-referencing across analytical databases and laboratory information systems.

Supplied as a synthetic, lyophilized white to off-white powder under catalog identifier AOD-9604, this reference material carries a specified purity of not less than 98% as determined by reverse-phase HPLC, with identity typically corroborated by ESI or MALDI mass spectrometry against the expected monoisotopic mass. The composition includes multiple polar and ionizable residues (two arginines, one glutamic acid, two serines, one glutamine, one tyrosine) alongside hydrophobic isoleucine, leucine, valine, and phenylalanine side chains, giving AOD-9604 a mixed amphipathic character relevant to solvent selection, reconstitution studies, and stability profiling in analytical workflows.

Published scientific literature has examined AOD-9604 in preclinical research; PEPTIDE.Power makes no therapeutic, diagnostic, or efficacy claims regarding this material and provides no administration or dosing guidance. As a cyclic disulfide-containing peptide, AOD-9604 warrants standard handling considerations for cysteine-bearing sequences, including protection from oxidative and reductive conditions during reference-standard preparation, and storage of the lyophilizate under cool, dry, light-protected conditions to preserve analytical integrity.

This material is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion. Identity and purity for each production lot of AOD-9604 are documented on a lot-specific Certificate of Analysis, available on request, which reports HPLC purity, mass-spectrometric identity confirmation, appearance, and applicable residual-solvent or counterion data to support reproducibility in downstream analytical and comparative laboratory studies.

Physical format

Supplied as a lyophilized (freeze-dried) powder in a sealed vial. A research reference material - not a finished product and not a delivery device. Net contents per unit are shown in the product options.

Certificate of Analysis

AnalyteAOD-9604
CAS Number221231-10-3
AppearanceWhite to off-white lyophilized powder
IdentityConfirmed by HPLC and mass spectrometry

Lot-specific COA available — contact [email protected] with your lot number.

Storage & handling

Store the sealed lyophilized powder at -20 C, protected from light and moisture. After reconstitution for laboratory use, keep cold and use promptly. Handle per standard laboratory practice; a Safety Data Sheet (SDS) is available on request.

Scientific references

The following are independent, peer-reviewed publications provided for reference. They describe third-party research and are not representations by POWER BIOTECH LLC regarding this product.

  1. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone — https://pubmed.ncbi.nlm.nih.gov/11146367/
  2. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice — https://pubmed.ncbi.nlm.nih.gov/11713213/
  3. Obesity pharmacotherapy: current perspectives and future directions — https://pmc.ncbi.nlm.nih.gov/articles/PMC3584306/
  4. Obesity drugs in clinical development — https://pubmed.ncbi.nlm.nih.gov/16625817/
  5. Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors — https://pubmed.ncbi.nlm.nih.gov/16931496/

Eligibility & terms of sale

This material is sold to qualified laboratory and research buyers for lawful research use only. It is not a drug, supplement, cosmetic, or food, and is not for human or veterinary use, injection, or ingestion. By purchasing, you confirm you are 21 or older and will use this material only for lawful laboratory research.

FAQ

What is the purity and how is it verified?
Not less than 98% by HPLC; see the Certificate of Analysis for the lot-specific result.

What form does it ship in?
A lyophilized powder in a sealed vial.

Can you advise on dosing, reconstitution, or administration?
No. We provide batch documentation, storage, and handling information only; we do not provide dosing, reconstitution, administration, or therapeutic guidance.

Is lot-specific documentation available?
Yes - contact [email protected] with your lot number for the Certificate of Analysis.

Related reference materials

Sold by POWER BIOTECH LLC, Casper, WY 82609, United States · [email protected]. FOR LABORATORY RESEARCH USE ONLY. Not a drug, supplement, cosmetic, or food. Not for human or veterinary use, ingestion, injection, or any in-vivo administration. Not evaluated by the FDA.